Gottlieb outlines FDA plan to keep generics cheap

08:06 EDT 22 Jun 2017 | pharmaphorum

The FDA’s new commissioner Scott Gottlieb has outlined plans to make generic drugs more affordable, by preventing 'gaming' of the regulator's approval system. This is an extension of a plan to tackle the backlog of 2,600 generic drug application...

Original Article: Gottlieb outlines FDA plan to keep generics cheap


More From BioPortfolio on "Gottlieb outlines FDA plan to keep generics cheap"

Quick Search


Relevant Topics

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Generics Drugs
A generic drug (generic drugs, short: generics) is a drug defined as "a drug product that is comparable to brand/reference listed drug product in dosage form, strength, route of administration, quality and performance characteristics, and intended u...